poisar

Stocks · News reference

Masimo Receives FDA 510(k) Clearance for smartSedLine™ Brain Function Monitoring Solution

Fiscal.ai

Masimo, a Danaher company, has received U.S. Food and Drug Administration (FDA) 510(k) clearance for its new smartSedLine™ brain function monitoring technology.

Reference Details

Connected Markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

Source
fiscal.ai
Observed
Checked
Cadence
Captured once, then retained as an archive reference
Status
fresh

Keep reading